Detection of metabolic adaptation in a triple-negative breast cancer animal model with [<sup>18</sup>F]choline-PET imaging as a surrogate for drug resistance. | IRIC – Institut de recherche en immunologie et en cancérologie de l’Université de Montréal

Publication — IRIC

Detection of metabolic adaptation in a triple-negative breast cancer animal model with [¹⁸F]choline-PET imaging as a surrogate for drug resistance.

Test the feasibility of an image-based method to identify taxane resistance in mouse bearing triple-negative breast cancer (TNBC) tumor xenografts.

Date de publication: 14 décembre 2023
Chercheur(euse)s: Kohan AA, Lupien M, Cescon D, Deblois G, Ventura M, Metser U, Veit-Haibach P
Référence PubMed: Eur J Nucl Med Mol Imaging 2023
ID PubMed: 38095672
Affiliation: University Medical Imaging Toronto, Toronto Joint Department Medical Imaging, University Health Network, Sinai Health System, Women’s College Hospital, 263 McCaul St 4th floor, Toronto, ON, M5T 1W7, Canada. Andres.Kohan@uhn.ca.